The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 39 | — | 20.1x | Near average | |
Growth | 50 | 44.9% | 5.6% | Near average | |
Quality | 34 | -16.3% | 7.6% | Below average | |
Safety | 27 | 1.5x | 0.4x | Below average | |
Capital Return | 30 | — | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Legend Biotech Corporation is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Legend Biotech Corporation shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Legend Biotech stock has seen a gradual improvement in its Consensus price target over the last 30 days, rising from 58 to 59.78 dollars, an increase of 3.07%. This rise is driven by a new analyst joining the coverage, bringing the number of analysts to 5, while maintaining positive ratings from major institutions such as Morgan Stanley and H.C. Wainwright. This trend reflects cautious optimism despite the current price gap between the market price (35.98) and the average target.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.